244 related articles for article (PubMed ID: 38054666)
1. Long-term health consequences of central precocious/early puberty (CPP) and treatment with Gn-RH analogue: a short update.
Soliman AT; Alaaraj N; De Sanctis V; Hamed N; Alyafei F; Ahmed S
Acta Biomed; 2023 Dec; 94(6):e2023222. PubMed ID: 38054666
[TBL] [Abstract][Full Text] [Related]
2. Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females.
Bertelloni S; Baroncelli GI; Sorrentino MC; Perri G; Saggese G
Eur J Pediatr; 1998 May; 157(5):363-7. PubMed ID: 9625331
[TBL] [Abstract][Full Text] [Related]
3. MANAGEMENT OF ENDOCRINE DISEASE: Long-term outcomes of the treatment of central precocious puberty.
Guaraldi F; Beccuti G; Gori D; Ghizzoni L
Eur J Endocrinol; 2016 Mar; 174(3):R79-87. PubMed ID: 26466612
[TBL] [Abstract][Full Text] [Related]
4. Gonadotropin-suppressive therapy in girls with early and fast puberty affects the pace of puberty but not total pubertal growth or final height.
Lazar L; Kauli R; Pertzelan A; Phillip M
J Clin Endocrinol Metab; 2002 May; 87(5):2090-4. PubMed ID: 11994346
[TBL] [Abstract][Full Text] [Related]
5. Final adult height in children with central precocious puberty - a retrospective study.
Knific T; Lazarevič M; Žibert J; Obolnar N; Aleksovska N; Šuput Omladič J; Battelino T; Avbelj Stefanija M
Front Endocrinol (Lausanne); 2022; 13():1008474. PubMed ID: 36531464
[TBL] [Abstract][Full Text] [Related]
6. Effect of gonadotropin-releasing hormone analog on ovarian reserve in children with central precocious puberty.
Tao Y; Si C; Li H; Han J; Hou H; Yang M
Ann Palliat Med; 2020 Jan; 9(1):53-62. PubMed ID: 32005063
[TBL] [Abstract][Full Text] [Related]
7. A Critical Appraisal of the Effect of Gonadotropin-Releasing Hormon Analog Treatment on Adult Height of Girls with Central Precocious Puberty.
Bereket A
J Clin Res Pediatr Endocrinol; 2017 Dec; 9(Suppl 2):33-48. PubMed ID: 29280737
[TBL] [Abstract][Full Text] [Related]
8. Use of a Gonadotropin-releasing Hormone Analog to Treat Idiopathic Central Precocious Puberty Is Not Associated with Changes in Bone Structure in Postmenarchal Adolescents.
Iannetta R; Melo AS; Iannetta O; Marchini JS; Paula FJ; Martinelli CE; Rosa e Silva AC; Ferriani RA; Martins WP; Reis RM
J Pediatr Adolesc Gynecol; 2015 Oct; 28(5):304-8. PubMed ID: 26081481
[TBL] [Abstract][Full Text] [Related]
9. Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty.
Paterson WF; McNeill E; Young D; Donaldson MD
Clin Endocrinol (Oxf); 2004 Nov; 61(5):626-34. PubMed ID: 15521967
[TBL] [Abstract][Full Text] [Related]
10. [Effect of treatment with gonadotropin releasing hormone analogues in girls with idiopathic central precocious puberty].
Ságodi L; Sólyom E; Lombay B; Almási A; Vámosi I
Orv Hetil; 2012 Mar; 153(11):418-24. PubMed ID: 22390866
[TBL] [Abstract][Full Text] [Related]
11. Progression of premature thelarche to central precocious puberty.
Pasquino AM; Pucarelli I; Passeri F; Segni M; Mancini MA; Municchi G
J Pediatr; 1995 Jan; 126(1):11-4. PubMed ID: 7815198
[TBL] [Abstract][Full Text] [Related]
12. Central precocious puberty: clinical and laboratory features.
Chemaitilly W; Trivin C; Adan L; Gall V; Sainte-Rose C; Brauner R
Clin Endocrinol (Oxf); 2001 Mar; 54(3):289-94. PubMed ID: 11298079
[TBL] [Abstract][Full Text] [Related]
13. Gonadotropin releasing hormone agonist treatment to increase final stature in children with precocious puberty: a meta-analysis.
Li P; Li Y; Yang CL
Medicine (Baltimore); 2014 Dec; 93(27):e260. PubMed ID: 25501098
[TBL] [Abstract][Full Text] [Related]
14. Toward More Targeted and Cost-Effective Gonadotropin-Releasing Hormone Analog Treatment in Girls with Central Precocious Puberty.
Kaplowitz PB; Backeljauw PF; Allen DB
Horm Res Paediatr; 2018; 90(1):1-7. PubMed ID: 30048994
[TBL] [Abstract][Full Text] [Related]
15. Menstrual cycle, reproductive function, body mass index, and metabolic profiles of women with former central precocious puberty: 10-20-year longitudinal cohort study in southern Thailand.
Satitpatanapan P; Jaruratanasirikul S; Sriplung H
J Pediatr Endocrinol Metab; 2020 Jul; 33(7):933-940. PubMed ID: 32623380
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of Patients with Central Precocious Puberty Due to Loss-of-Function Mutations in the MKRN3 Gene after Treatment with Gonadotropin-Releasing Hormone Analog.
Ramos CO; Macedo DB; Canton APM; Cunha-Silva M; Antonini SRR; Stecchini MF; Seraphim CE; Rodrigues T; Mendonca BB; Latronico AC; Brito VN
Neuroendocrinology; 2020; 110(7-8):705-713. PubMed ID: 31671431
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Triptorelin 3-Month Formulation in Chinese Children with Central Precocious Puberty: A Phase 3, Open-Label, Single-Arm Study.
Luo X; Zhang C; Yang Y; Xu X; Cheng X; Wei H; Wang L; Huang F; Shi X; Cabri P
Adv Ther; 2023 Oct; 40(10):4574-4588. PubMed ID: 37584898
[TBL] [Abstract][Full Text] [Related]
18. [Advances in the etiology, diagnosis and treatment of central precocious puberty].
Macedo DB; Cukier P; Mendonca BB; Latronico AC; Brito VN
Arq Bras Endocrinol Metabol; 2014 Mar; 58(2):108-17. PubMed ID: 24830587
[TBL] [Abstract][Full Text] [Related]
19. Serum Levels of Thyroid Stimulating Hormone and Luteinizing Hormone Are Decreased in Girls with Central Precocious Puberty after 12-Month GnRH Agonist Treatment.
Kim YJ; Chung LY; Kang E; Nam HK; Rhie YJ; Lee KH
Tohoku J Exp Med; 2020 Nov; 252(3):193-197. PubMed ID: 33087637
[TBL] [Abstract][Full Text] [Related]
20. Approach to the Patient: Central Precocious Puberty.
Kilberg MJ; Vogiatzi MG
J Clin Endocrinol Metab; 2023 Jul; 108(8):2115-2123. PubMed ID: 36916130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
